Table 4:
Studies examining outcomes after EVR.
| Author | Year | n | Type of data | Primary factors associated with reintervention |
Follow-up |
|---|---|---|---|---|---|
| Hobo20 | 2007 | 5,183 | Clinical registry (EUROSTAR) | Type 1 endoleak | 5 years |
| Schanzer21 | 2011 | 10,228 | Imaging (M2S) | Reintervention not reported | 5 years |
| Schermerhorn2 | 2016 | 39,966 | Medicare claims | No factors studied | 8 years |
| Huang15 | 2017 | 874 | Clinical, single center | Aneurysm ≥6·0 cm | 5 years |
| Grootes22 | 2018 | 785 | RCT (EVAR-1 and EVAR-2) | Aneurysm sac diameter and growth | 5 years |
| Columbo | 2018 | 12,911 | Clinical registry (VQI) and Medicare claims | Current study | 10 years |
Legend: RCT, randomized controlled trial.